Novel molecular, cytotoxical, and immunological study on promising and selective anticancer activity of Mung bean sprouts

被引:36
|
作者
Hafidh, Rand R. [2 ,3 ]
Abdulamir, Ahmed S. [1 ,3 ]
Abu Bakar, Fatimah [3 ]
Jalilian, Farid Azizi [4 ,5 ]
Abas, Faridah [3 ,6 ]
Sekawi, Zamberi [4 ]
机构
[1] Al Nahrain Univ, Coll Med, Dept Microbiol, Baghdad, Iraq
[2] Univ Baghdad, Coll Med, Dept Microbiol, Baghdad, Iraq
[3] Univ Putra Malaysia, Inst Biosci, Upm Serdang 43400, Selangor Darul, Malaysia
[4] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med Microbiol & Parasitol, Upm Serdang 43400, Selangor Darul, Malaysia
[5] Ilam Univ Med Sci, Clin Microbiol Res Ctr, Ilam, Iran
[6] Univ Putra Malaysia, Dept Food Sci, Fac Food Sci & Technol, Upm Serdang 43400, Selangor Darul, Malaysia
关键词
ALPHA-TOCOPHERYL SUCCINATE; BLOOD MONONUCLEAR-CELLS; BREAST-CANCER; TNF-ALPHA; VITAMIN-E; IN-VITRO; PHENOLIC-COMPOUNDS; INTERFERON-BETA; ASCORBIC-ACID; CYCLIN D1;
D O I
10.1186/1472-6882-12-208
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: The anticancer and immunomodulatory activity of mung bean sprouts (MBS) and the underlying mechanisms against human cervical and hepatocarcinoma cancer cells were explored. Methods: MBS cytotoxicity and MBS-induced anticancer cytokines, TNF-alpha and IFN-beta from cancer cells, and immunological cytokines, IL-4, IFN-gamma, and IL-10 from peripheral mononuclear cells (PMNC) were assessed by MTS and ELISA assays. Apoptotic cells were investigated by flow cytometry. The expression level of apoptotic genes (Bax, BCL-2, Capsases 7-9) and cell cycle regulatory genes (cyclin D, E, and A) and tumor suppressor proteins (p27, p21, and p53) was assessed by real-time qPCR in the cancer cells treated with extract IC50. Results: The cytotoxicity on normal human cells was significantly different from HeLa and HepG2 cells, 163.97 +/- 5.73, 13.3 +/- 0.89, and 14.04 +/- 1.5 mg/ml, respectively. The selectivity index (SI) was 12.44 +/- 0.83 for HeLa and 11.94 +/- 1.2 for HepG2 cells. Increased levels of TNF-alpha and IFN-beta were observed in the treated HeLa and HepG2 culture supernatants when compared with untreated cells. MBS extract was shown to be an immunopolarizing agent by inducing IFN gamma and inhibiting IL-4 production by PBMC; this leads to triggering of CMI and cellular cytotoxicity. The extract induced apoptosis, in a dose and time dependent manner, in treated HeLa and HepG2, but not in untreated, cells (P < 0.05). The treatment significantly induced cell cycle arrest in G0/G1 in HeLa cells. The percentage of cells in G0/G1 phase of the treated HeLa cells increased from 62.87 +/- 2.1%, in untreated cells, to 80.48 +/- 2.97%. Interestingly, MBS IC50 induced the expression of apoptosis and tumor suppressor related genes in both HeLa and HepG2 cells. MBS extract succeeded in inducing cdk-inhibitors, p21, p53, and p27 in HeLa cells while it induced only p53 in HepG2 cells (P < 0.05). This is a clue for the cell type-specific interaction of the studied extract. These proteins inhibit the cyclin-cdk complexes apart from the presence of some other components that might stimulate some cyclins such as cyclin E, A, and D. Conclusion: MBS extract was shown to be a potent anticancer agent granting new prospects of anticancer therapy using natural products.
引用
收藏
页数:24
相关论文
共 50 条
  • [31] β-Lactams as promising anticancer agents: Molecular hybrids, structure activity relationships and potential targets
    Fu, Dong-Jun
    Zhang, Yun-Feng
    Chang, An-Qi
    Li, Jun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 201
  • [32] Synthesis and Biological Activity Characterization of Novel 5-Oxopyrrolidine Derivatives with Promising Anticancer and Antimicrobial Activity
    Kairyte, Karolina
    Grybaite, Birute
    Vaickelioniene, Rita
    Sapijanskaite-Banevic, Birute
    Kavaliauskas, Povilas
    Mickevicius, Vytautas
    PHARMACEUTICALS, 2022, 15 (08)
  • [33] Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling
    Huang, Xiao Y.
    Shan, Zhi J.
    Zhai, Hong L.
    Su, Li
    Zhang, Xiao Y.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (04) : 651 - 658
  • [34] Discovery of a novel series of substituted quinolines acting as anticancer agents and selective EGFR blocker: Molecular docking study
    Kumar, C. B. Pradeep
    Raghu, M. S.
    Prathibha, B. S.
    Prashanth, M. K.
    Kanthimathi, G.
    Kumar, K. Yogesh
    Parashuram, L.
    Alharthi, Fahad A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 44
  • [35] Novel dermacozine-1-carboxamides as promising anticancer agents with tubulin polymerization inhibitory activity
    Ghanta, Venkata Rao
    Madala, Nagaraju
    Pasula, Aparna
    Pindiprolu, Sai Kiran S. S.
    Battula, Kumara Swamy
    Krishnamurthy, Praveen T.
    Raman, Balamurali
    RSC ADVANCES, 2019, 9 (32) : 18670 - 18677
  • [36] IMMUNOLOGICAL EVIDENCE FOR THE OCCURRENCE OF MATURATION-SPECIFIC MESSENGER-RNA FOR A LOW MOLECULAR-WEIGHT PROTEIN IN DRY MUNG-BEAN SEEDS
    CARLIER, AR
    MANICKAM, A
    PEUMANS, WJ
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1980, 88 (01): : B15 - B16
  • [37] SYNTHESIS, ANTICANCER ACTIVITY AND MOLECULAR DOCKING STUDY OF SOME NOVEL 2-THIOURACIL SULFONAMIDE DERIVATIVES
    Awad, S. M.
    Ahmed, N. M.
    Haffez, H. R.
    PHARMACOPHORE, 2018, 9 (01): : 30 - 41
  • [38] Synthesis, anticancer activity and molecular modeling study of novel substituted triazole linked tetrafluoronaphthalene hybrid derivatives
    Erdogan, Musa
    Comert Onder, Ferah
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (18): : 9767 - 9786
  • [39] Molecular Docking Study of Isoxazole Indole Derivatives (B2A2 Series) as Promising Selective Estrogen Receptor Modulators & Anticancer Drugs
    Iyer, Jayashree Monikanta
    Khare, Aradhana
    Pandey, Jaya
    Yadav, Manish
    DRUG RESEARCH, 2023, 73 (02) : 75 - 87
  • [40] Novel N-Acyl Hydrazone Compounds as Promising Anticancer Agents: Synthesis and Molecular Docking Studies
    Biliz, Yagmur
    Hasdemir, Belma
    Kucuk, Hatice Baspinar
    Zaim, Merve
    Senturk, Ahmet Mesut
    Kirmizibekmez, Aynur Muduroglu
    Kara, Ihsan
    ACS OMEGA, 2023, 8 (22): : 20073 - 20084